Citius Pharmaceuticals Inc (CTXR)
0.434
-0.01
(-2.60%)
USD |
NASDAQ |
Oct 04, 16:00
0.435
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Shareholders Equity (Annual): 90.83M for Sept. 30, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 90.83M |
| September 30, 2022 | 102.83M |
| September 30, 2021 | 132.18M |
| September 30, 2020 | 33.67M |
| September 30, 2019 | 27.15M |
| September 30, 2018 | 27.87M |
| September 30, 2017 | 21.95M |
| Date | Value |
|---|---|
| September 30, 2016 | 16.77M |
| September 30, 2015 | -0.6352M |
| September 30, 2014 | -0.7419M |
| September 30, 2013 | -0.0147M |
| September 30, 2012 | -0.0458M |
| September 30, 2011 | -0.0238M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
33.67M
Minimum
2020
132.18M
Maximum
2021
89.88M
Average
96.83M
Median
Shareholders Equity (Annual) Benchmarks
| Agilent Technologies Inc | 5.845B |
| Seelos Therapeutics Inc | -33.51M |
| Cara Therapeutics Inc | 57.08M |
| Moleculin Biotech Inc | 26.07M |
| Citius Oncology Inc | -- |